Industry News
Sugar Used To Halt Esophageal Cancer In Its Tracks
Jan 17, 2012
Scientists working at the Medical Research Council have identified changes in the patterns of sugar molecules that line pre-cancerous cells in the esophagus, a condition called Barrett's dysplasia, making it much easier to detect and remove these cells before they develop into esophageal cancer... Read More
Researchers Discover Novel Chemical Route To Form Organic Molecules
Jan 17, 2012
An international team of scientists led by University of Hawaii at Manoa Professor Ralf I. Kaiser, Alexander M... Read More
Predicting The Value Of Indexing Symptoms For Ovarian Cancer
Jan 17, 2012
The use of symptom indices to identify patients with symptoms associated with ovarian cancer who may need further screening is increasing in both the UK and the US in an attempt to promote earlier diagnosis, but they may need to be reassessed in order to help better detect cancer, according to a study published January 13 in the Journal of the National Cancer Institute... Read More
Imaging Technology For Looking Inside Brain May Help Test New Brain Cancer Drugs
Jan 16, 2012
Using imaging technology that reveals whether brain tumors have a particular genetic mutation known as IDH, a team of academic and pharmaceutical company researchers has developed a way to help doctors select the right treatment, and developers to make new drugs that target the mutation... Read More
In Ovarian Cancer, Faulty Proteins May Prove Significant In Identifying New Treatments
Jan 16, 2012
OHSU Knight Cancer Institute study results suggest that more patients than initially thought could potentially be treated with a new class of drugs, PARP inhibitors A constellation of defective proteins suspected in causing a malfunction in the body's ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a... Read More
Discovery Of Genes And Disease Mechanisms Behind Muscular Dystrophy Could Lead To A Biomarker-Based Diagnostic Test
Jan 16, 2012
Continuing a series of groundbreaking discoveries begun in 2010 about the genetic causes of the third most common form of inherited muscular dystrophy, an international team of researchers led by a scientist at Fred Hutchinson Cancer Research Center has identified the genes and proteins that damage muscle cells, as well as the mechanisms that can cause the disease... Read More
Chlorophyll Can Help Prevent Cancer - But Study Raises Other Questions
Jan 16, 2012
A recent study at Oregon State University found that the chlorophyll in green vegetables offers protection against cancer when tested against the modest carcinogen exposure levels most likely to be found in the environment. However, chlorophyll actually increases the number of tumors at very high carcinogen exposure levels... Read More
Possible Receptor For Key Breast Cancer Regulator Identified By Researchers
Jan 16, 2012
A key protein potentially involved in regulating breast cancer progression has been identified by researchers at Clarkson University in Potsdam, N.Y. Led by professor Costel Darie, the team worked to identify the binding partner of Tumor Differentiating Factor (TDF), a pituitary hormone that had previously been shown to reduce cancer progression in breast cancer cells... Read More
In Ovarian Cancer, Faulty Proteins May Prove Significant In Identifying New Treatments
Jan 16, 2012
OHSU Knight Cancer Institute study results suggest that more patients than initially thought could potentially be treated with a new class of drugs, PARP inhibitors A constellation of defective proteins suspected in causing a malfunction in the body's ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a... Read More
Newly Identified Genetic Alterations In T-ALL Provide New Potential Treatment Strategies For Devastating Childhood Leukemia
Jan 15, 2012
A new study published in the journal Nature Medicine by NYU Cancer Institute researchers, shows how the cancer causing gene Notch, in combination with a mutated Polycomb Repressive Complex 2 (PRC2) protein complex, work together to cause T- cell acute lymphoblastic leukemia (T-ALL). T-ALL is an aggressive blood cancer, predominately diagnosed in children... Read More
Previous Page Next Page